These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 4431057)
61. A new differentiation antigen of plasma cells. Takahashi T; Old LJ; Hsu CJ; Boyse EA Eur J Immunol; 1971 Dec; 1(6):478-82. PubMed ID: 4947913 [No Abstract] [Full Text] [Related]
62. Functional efficiency of antitumor cytotoxic lymphoid cells. Wunderlich JR; Martin WJ; Macdonald J Isr J Med Sci; 1973 Mar; 9(3):317-23. PubMed ID: 4710039 [No Abstract] [Full Text] [Related]
63. The formalinization of antibody to tumor cells in altering the immune response. Ungaro PC; Drake WP; Mardiney MR Cancer Res; 1972 Oct; 32(10):2241-7. PubMed ID: 4117036 [No Abstract] [Full Text] [Related]
64. Identification of tumor-associated antigens on ultraviolet light-induced tumors using antitumor antibodies developed in ascites fluid. Fortner GW; Takemoto LJ; Shehi L; Hansen JS Cancer Res; 1982 Jun; 42(6):2371-4. PubMed ID: 7042083 [TBL] [Abstract][Full Text] [Related]
65. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations. Konda S; Smith RT Cancer Res; 1973 Aug; 33(8):1878-84. PubMed ID: 4541721 [No Abstract] [Full Text] [Related]
66. [Antitumor activity of the lymphoid spleen cells of hepatectomized C3HA strain mice]. Malygin AM; Fel' VIa Tsitologiia; 1982 Dec; 24(12):1460-2. PubMed ID: 7157475 [No Abstract] [Full Text] [Related]
67. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens. Harada M; Pearson G; Pettigrew H; Redmon L; Orr T Cancer Res; 1973 Nov; 33(11):2886-93. PubMed ID: 4583975 [No Abstract] [Full Text] [Related]
68. Natural antibodies directed against murine lymphosarcoma cells: variability of level in individual mice. Pierotti MA; Colnaghi MI Int J Cancer; 1976 Aug; 18(2):223-9. PubMed ID: 989042 [TBL] [Abstract][Full Text] [Related]
69. Cytocidal effect of rifamycin derivatives on ascites tumor cells: studies with [125I]iododeoxyuridine. Hughes AM; Calvin M Cancer Lett; 1979 Jan; 6(1):15-9. PubMed ID: 544007 [TBL] [Abstract][Full Text] [Related]
70. A terminal-labelling microcytotoxicity assay with 125I-iododeoxyuridine as a label for target cells. Stirrat GM J Immunol Methods; 1976; 12(3-4):201-18. PubMed ID: 987115 [TBL] [Abstract][Full Text] [Related]
72. Microassay using radioiodinated protein A from Staphylococcus aureus for antibodies bound to cell surface antigens of adherent tumor cells. Zeltzer PM; Seeger RC J Immunol Methods; 1977; 17(1-2):163-75. PubMed ID: 903615 [TBL] [Abstract][Full Text] [Related]
73. Humoral immunostimulation. II. Increased nucleoside incorporation, DNA synthesis, and cell growth in L cells treated with anti-L cell antibody. Shearer WT; Philpott GW; Parker CW Cell Immunol; 1975 Jun; 17(2):447-62. PubMed ID: 1125994 [No Abstract] [Full Text] [Related]
74. Ga-citrate and I-iododeoxyuridine as markers for in vivo evaluation of tumor cell metastasis and death. Hofer KG; Swartzendruber DC J Natl Cancer Inst; 1973 Apr; 50(4):1039-45. PubMed ID: 4703767 [No Abstract] [Full Text] [Related]